Integrated Wellness · The science, in context

Molecule
Library.

Understand the molecule. Question the claim.

Explore peptides and related molecules through mechanisms, published research and what we still don’t know. Clear science. No sales. No shortcuts.

A better research lens

Not all evidence is equal.

A promising mechanism is the beginning of a question—not the end of one.

01

Cells & models

What might happen?

02

Human studies

What happens in people?

03

Clinical outcomes

Does it meaningfully help?

04

Regulatory context

For which product and use?

Learn to read the evidence
35 molecule profiles10 research categoriesSource-linked. Education only.

A more visual way to learn

Take a trail. Trace a pathway.

Start with recovery, metabolism or longevity. Build your vocabulary, explore the biology and keep track of what you’ve read.

The research directory

Find a molecule. Follow the evidence.

35 of 35 molecules

Preclinical1 sources

5-Amino-1MQ

Metabolic health

Small-molecule NNMT inhibitor; not a peptide. Adipose metabolism and metabolic dysfunction in experimental models.

Not FDA-approved

Human research1 sources

AOD-9604

Metabolic health

Modified growth-hormone fragment. Whether a GH-derived fragment can influence lipid metabolism without reproducing all GH effects.

Not FDA-approved

Preclinical1 sources

BPC-157

Tissue repair

Synthetic pentadecapeptide (15 amino acids). Tendon, ligament, muscle and gastrointestinal injury models.

Not FDA-approved

Human research1 sources

CJC-1295

Hormonal signaling

Long-acting GHRH analog. GH and IGF-1 responses and pharmacokinetics in controlled research.

Not FDA-approved

Human research1 sources

CagriSema

Metabolic health

Investigational semaglutide–cagrilintide combination. Combined GLP-1 and amylin signaling for metabolic outcomes.

Not FDA-approved

Human research1 sources

Cagrilintide

Metabolic health

Long-acting amylin analog. Appetite regulation and body-weight outcomes in controlled studies.

Not FDA-approved

Limited / uncertain1 sources

DSIP

Sleep & circadian

Delta sleep-inducing nonapeptide. Historical sleep architecture and stress-response hypotheses.

Not FDA-approved

Preclinical1 sources

Dihexa

Cognitive research

Angiotensin-IV-derived peptidomimetic. Synaptic plasticity and cognitive behavior in experimental models.

Not FDA-approved

Preclinical1 sources

Epitalon

Longevity

Synthetic AEDG tetrapeptide. Telomerase, telomere maintenance and pineal-related biology.

Not FDA-approved

Preclinical1 sources

FOXO4-DRI

Longevity

D-retro-inverso research peptide. Selective removal of senescent cells in laboratory models.

Not FDA-approved

Human research1 sources

GHK-Cu

Skin science

Copper-binding tripeptide complex. Topical skin remodeling and extracellular-matrix biology.

Not FDA-approved as a drug

Human research1 sources

GHRP-2

Hormonal signaling

Synthetic growth-hormone-releasing peptide (pralmorelin). Human endocrine responses and GH-stimulation testing.

Not FDA-approved

Human research1 sources

GHRP-6

Hormonal signaling

Synthetic hexapeptide secretagogue. GH secretion and related endocrine feedback.

Not FDA-approved

Human research1 sources

Hexarelin

Hormonal signaling

Synthetic hexapeptide secretagogue. Pituitary endocrine responses compared with ghrelin and GHRH.

Not FDA-approved

Preclinical1 sources

Humanin

Longevity

Mitochondrial-derived peptide. Cell survival and neuroprotection hypotheses.

Not FDA-approved

Preclinical2 sources

IGF-1 LR3

Muscle performance

Modified long-acting IGF-1 analog. Growth-factor signaling in cell culture and animal models.

Not FDA-approved

Human research2 sources

Ipamorelin

Hormonal signaling

Synthetic pentapeptide secretagogue. GH signaling and gastrointestinal motility research.

Not FDA-approved

Preclinical1 sources

KPV

Gut health

Lys-Pro-Val tripeptide related to alpha-MSH. Intestinal inflammatory signaling and experimental colitis.

Not FDA-approved

Human research2 sources

Kisspeptin-10

Hormonal signaling

Kisspeptin decapeptide fragment. Reproductive hormone signaling and GnRH/LH responses.

Not FDA-approved

Human research1 sources

LL-37

Immune pathways

Human cathelicidin antimicrobial peptide. Antimicrobial defense, wound biology and immune signaling.

Not FDA-approved

Preclinical1 sources

MOTS-c

Metabolic health

Mitochondrial-derived 16-amino-acid peptide. Metabolic stress, insulin sensitivity and skeletal-muscle signaling.

Not FDA-approved

Limited / uncertain1 sources

Melanotan II

Skin science

Nonselective melanocortin receptor agonist. Pigmentation and historical sexual-function research.

Not FDA-approved

Limited / uncertain1 sources

P21

Cognitive research

CNTF-derived research-peptide label. Neurogenesis and cognition in preclinical research.

Not FDA-approved

Preclinical2 sources

PEG-MGF

Muscle performance

Pegylated MGF-related research construct. Muscle progenitor-cell and growth-factor biology.

Not FDA-approved

Human outcomes1 sources

PT-141 / Bremelanotide

Hormonal signaling

Bremelanotide; melanocortin receptor agonist. Sexual-desire outcomes within a narrowly defined clinical indication.

FDA-approved product · narrow indication

Human research1 sources

Retatrutide

Metabolic health

Investigational triple-receptor agonist. Body-weight and metabolic outcomes in controlled trials.

Not FDA-approved

Human research1 sources

SS-31 / Elamipretide

Longevity

Elamipretide; mitochondria-targeted tetrapeptide. Mitochondrial membrane function and disease-specific outcomes.

FDA accelerated approval · Barth syndrome

Limited / uncertain1 sources

Selank

Cognitive research

Synthetic tuftsin-related heptapeptide. Anxiety-related signaling and neurobehavioral hypotheses.

Not FDA-approved

Human outcomes3 sources

Semaglutide

Metabolic health

GLP-1 receptor agonist. Glycemic, weight and cardiovascular outcomes in defined patient groups.

FDA-approved products · specific indications

Limited / uncertain1 sources

Semax

Cognitive research

Synthetic ACTH-fragment analog. Neuropeptide signaling and neurological research hypotheses.

Not FDA-approved

Human research1 sources

Sermorelin

Hormonal signaling

GHRH (1–29) analog. Pituitary GH response and historical pediatric GH-deficiency research.

Historical FDA product · discontinued

Preclinical1 sources

TB-500

Tissue repair

Thymosin-beta-4-related fragment label. Cell migration and tissue-repair hypotheses.

Not FDA-approved

Human outcomes1 sources

Tesamorelin

Metabolic health

GHRH analog. Visceral adipose tissue in adults with HIV-associated lipodystrophy.

FDA-approved product · narrow indication

Human research1 sources

Thymosin Alpha-1

Immune pathways

Thymosin alpha-1 (thymalfasin), a 28-amino-acid peptide. Immune regulation in infection and other disease-specific studies.

Not FDA-approved

Human outcomes2 sources

Tirzepatide

Metabolic health

Dual GIP/GLP-1 receptor agonist. Glycemic and weight outcomes and other labeled disease-specific outcomes.

FDA-approved products · specific indications

Entries may appear in more than one category. Category placement describes research interest, not proven benefit. This is a curated selection, not a systematic review; source gaps are identified inside each profile.

Beyond the library

Turn better questions into a thoughtful conversation.

Explore our broader health optimization approach. A library entry does not mean a molecule is offered, prescribed, or appropriate for you.

Request an Optimization Consultation

Continue to our existing activation & intake page.

Education, not a prescription. Research summaries are not medical advice, dosing instructions, or an offer to sell. Mechanistic findings do not establish clinical effectiveness. US regulatory status is product- and indication-specific and may change. Discuss health decisions with a licensed clinician.